Searching for "0241.HK"
Found 121 result(s)
Showing 10 article(s). 111 more available to premium subscribers.
Battered by the COVID-19 pandemic in Q1 2020, total market cap of China's publicly traded Internet companies dropped 4.2% QoQ to RMB 11.10 trln, reports the Policy and Economics Research Institute of the China Academy of Information and Communications Technology (CAICT), a department of China's Ministry of Industry and Information Technology (MIIT). Read More
Chinese e-commerce conglomerate Alibaba Group's (NYSE: BABA) healthcare subsidiary Alibaba Health Information Technology (0241.HK) recently launched a new authoritative health and medical information look-up service called Yijulu, in partnership with government, medical, and media organizations including China's national-level medicine and healthcare big data platform, Scientific and Technical Documentation Press, Beijing Cancer Hospital at Beijing University, and health magazine Jiankang Shibao. Read More
Chinese third-party payment platform Alipay recently announced that it will launch a one-stop medical services platform for users. Read More
Chinese e-commerce conglomerate Alibaba Group's (NYSE: BABA) healthcare subsidiary Alibaba Health Information Technology (0241.HK) recently announced a new smart healthcare program in partnership with nearly 20 Chinese medical device makers including Sinocare (300298.SZ), Haier Medical Technology, Kangsheng Health Management Consulting, Yuyue Medical Equipment and Supply (002223.SZ), Bayer Healthcare, and Omron. Read More
Beijing-based smart blood pressure monitor maker Kangkang Shengshi Information Technology recently completed RMB 8-digit Series A+ funding from undisclosed parties, revealed company chairman Zeng Mingfa. Read More
Chinese e-commerce conglomerate Alibaba Group's (NYSE: BABA) healthcare subsidiary Alibaba Health Information Technology (AliHealth) (0241.HK) recently launched a new third-party product tracking platform called Mashang Fangxin (unofficially "Rest Easy Code Check"), which will serve brand manufacturers, distributors, government agencies, and consumers. Read More
Tmall Drugstore, the third-party B2C medicine e-commerce platform operated by Alibaba Group's (NYSE: BABA) healthcare subsidiary Alibaba Health Information Technology (0241.HK), notified merchants on its platform today that they will no longer be allowed to sell over-the-counter (OTC) drugs anywhere in the country, according to a notice sent to Tmall Drugstore by the Hebei provincial branch of the China Food and Drug Administration (CFDA). Read More
Mobile health consultation and appointment booking app AliHealth, operated by Alibaba Group (NYSE: BABA) subsidiary Alibaba Health Information Technology (0241.HK), recently launched an Internet hospital service within its mobile app with services from Wuhan Central Hospital and Beijing United Family Hospital. Read More
Alibaba Health Information Technology (AliHealth) (0241.HK), the health services subsidiary of Chinese e-commerce conglomerate Alibaba Group (NYSE: BABA), plans to rebuild its third-party drug tracking platform, which was originally intended to mitigate the problem of counterfeit medications, announced AliHealth VP Wang Peiyu. Read More
Chinese e-commerce conglomerate Alibaba Group's (NYSE: BABA) healthcare subsidiary, Alibaba Health Information Technology (0241.HK) ("AliHealth"), recently partnered with Sinopharm Jiankang Zaixian, a subsidiary of Chinese state-owned pharmaceuticals conglomerate China National Pharmaceutical Group Corporation's Sinopharm Group (1099.HK), to launch a location-based "AliHealth Pharmaceuticals Search" platform for the AliHealth app. Read More